Co-pathology of synucleinopathy (Lewy Body inclusions) and proteinopathy (amyloid beta and tau) is a feature shared with other dementing conditions like DLB and AD, which makes it challenging to distinguish PD-related cognitive impairment from these co-pathologies (83). The gene discussed is MAPT; the disease is proteostasis deficiencies.